Laura Shawver

Laura Shawver has an extensive work experience spanning multiple companies and roles. Laura currently serves as a Member of the Board of Directors at ARS Pharmaceuticals, Inc. and as the President and Chief Executive Officer at Capstan Therapeutics. Laura has also held positions as a Member of the Board of Directors at Nkarta, Inc., Board Chair at Cleave Therapeutics, Inc., and a Member of the Board of Directors at Relay Therapeutics. In addition, they founded and directed The Clearity Foundation. Previously, they were the Chief Executive Officer of Silverback Therapeutics and the President and CEO of Synthorx Inc. Laura also served as CEO at Cleave Biosciences and as the Chief Executive Officer of Phenomix Corporation. Laura Shawver has a wealth of experience in leadership and board positions within the biotechnology industry.

Laura Shawver earned a Bachelor's Degree in Microbiology from the University of Iowa, where they attended from 1975 to 1979. Laura later pursued a Doctor of Philosophy (Ph.D.) in Pharmacology from the same university, completing their studies from 1979 to 1984. Prior to their university education, they attended Davenport Central from 1972 to 1975, although no degree or field of study information is provided for this period.